NLS PHARMACEUTICS LTD

CUSIP: H57830111 Class: *W EXP 02/02/202

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 424 Value ($000) $0 Avg Close — Range —
Q1 2024
Shares 6,023 Value ($000) $0 Avg Close — Range —
Q4 2023
Shares 1,000 Value ($000) $0 Avg Close — Range —
Q4 2022
Shares 3,745 Value ($000) $1 Avg Close — Range —
Q3 2022
Shares 15,547 Value ($000) $4 Avg Close — Range —
Q2 2022
Shares 2,086 Value ($000) $0 Avg Close — Range —
Q1 2022
Shares 1,990 Value ($000) $1 Avg Close — Range —
Q4 2021
Shares 2,635 Value ($000) $1 Avg Close — Range —
Q3 2021
Shares 2,635 Value ($000) $2 Avg Close — Range —
Q2 2021
Shares 3,346 Value ($000) $3 Avg Close — Range —
Q1 2021
Shares 3,119 Value ($000) $3 Avg Close — Range —